Eurofins Scientific SE
ERFSFOTCHealthcare● Active
$72.60
$-3.39(-4.46%)
Market Cap$12.7B
P/E Ratio—
52W High$86.2
52W Low$63.96
Eurofins Scientific SE (ERFSF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ERFSF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $7.29B | $6.95B | $6.51B | $6.71B | $6.72B |
| Cost of Revenue | $6.50B | $2.24B | $5.14B | $5.20B | $2.15B |
| Gross Profit | $0.79B | $4.71B | $1.37B | $1.51B | $4.57B |
| Gross Margin %(computed) | 10.87% | 67.79% | 21.10% | 22.54% | 68.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $3.99B | $0.14B | $0.13B | $3.30B |
| Operating Income | $0.79B | $0.73B | $1.24B | $0.78B | $1.26B |
| Operating Margin %(computed) | 10.87% | 10.45% | 19.02% | 11.67% | 18.77% |
| Interest Income | $0.03B | $0.02B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.17B | $0.15B | $0.13B | $0.11B | $0.17B |
| Income Before Tax | $0.65B | $0.55B | $0.42B | $0.78B | $1.06B |
| Income Tax Expense | $0.18B | $0.15B | $0.12B | $0.17B | $0.27B |
| Net Income | $0.47B | $0.41B | $0.31B | $0.61B | $0.78B |
| Net Margin %(computed) | 6.51% | 5.85% | 4.76% | 9.09% | 11.65% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $2.64 | $2.13 | $1.61 | $3.17 | $4.09 |
| Wtd Avg Shares | 0.18B | 0.19B | 0.24B | 0.19B | 0.19B |
| EBITDA | $1.45B | $1.37B | $1.22B | $1.35B | $1.54B |
| EBITDA Margin %(computed) | 19.86% | 19.66% | 18.68% | 20.15% | 22.95% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · EUR · B
Explore more Eurofins Scientific SE data
About Eurofins Scientific SE (ERFSF) Income Statement
Eurofins Scientific SE (ERFSF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ERFSF reported revenue of $7.29B, gross profit of $0.79B (gross margin 10.87%), and net income of $0.47B — a net profit margin of 6.51%.
Frequently asked questions
ERFSF · 4 questionsEurofins Scientific SE (ERFSF) reported revenue of $7.29B for 2025, up 4.9% year-over-year.
ERFSF revenueERFSF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09